Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most potent and perilous diseases known, with a median survival rate of 3-5 months due to the combination of only advanced stage diagnosis and ineffective therapeutic options. Metformin (1,1-Dimethylbiguanide hydrochloride), the leading drug used...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Curr Mol Med
Huvudupphovsmän: Zhou, G., Yu, J., Wang, A., Liu, S.-H., Sinnett-Smith, J., Wu, J., Sanchez, R., Nemunaitis, J., Ricordi, C., Rozengurt, E., Brunicardi, F.C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994969/
https://ncbi.nlm.nih.gov/pubmed/26695692
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk